MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Announces Preclinical Data on Type 1 Diabetes and Filing of Intellectual Property

SAN DIEGO, Oct. 3, 2013 (GLOBE NEWSWIRE) -- Medistem, Inc. (Pink Sheets: MEDS), announced today that it filed patent application #61/885909 covering immune modulatory aspects of ERC-124, the Company’s clinical-stage stem cell product.

Help employers find you! Check out all the jobs and post your resume.